SG Issuer
Notes to the financial statements
As at 31 December 2024
29
The group assesses on a forward-looking basis the
expected credit losses associated with
its debt instruments carried
at amortised cost. The impairment
methodology applied depends on
whether there has been a
significant increase in
credit
risk.
For
trade
receivables,
the
group
applies
the
simplified
approach
permitted
by
IFRS
9,
which
requires
expected lifetime losses to be recognised from initial recognition of the
receivables.
Impairment and provisions for credit risk
To
determine the amount of
impairment or loss allowances
to be recorded
at each reporting date,
these exposures
are classified
into one
of three categories
based on
the increase in
credit risk
observed since initial recognition.
An
impairment or loss allowance shall be recognised for the
exposures in each category as follows:
●
Exposures
classified
in
Stage
1:
At
the
initial
recognition
date,
the
exposures
are
systematically
classified
in
Stage
1, unless
they
are
underperforming/credit-impaired on
acquisition and
during
the lifetime
of
the credit.
Stage 1
exposures
are
impaired
for
the
amount
of
credit
losses
that
the
Company
expects
to
incur
within
12 months (12-month expected credit losses), based on
past data and the current situation;
●
Exposures classified in Stage 2: To
identify Stage 2 exposures, the significant
increase in credit risk is
assessed by
the
Company,
taking
into
account
the
counterparty’s
credit
risk
rating,
the
magnitude
of
the
change
in
the
counterparty’s credit rating and the existence of payments delays of more than 30 days;
●
Exposures classified in Stage 3 (doubtful
outstanding): The Company determines
whether or not there
is objective
evidence of impairment (default event).
Stage 2 and 3 exposures are impaired for the amount of credit losses that the Company expects to incur over the life
of
the
exposures
(lifetime
expected
credit
losses),
taking
into
consideration
past
data,
the
present
situation
and
reasonable forecast changes in economic conditions, and relevant macroeconomic factors through to maturity.
Impairments / Reversal of impairments
Impairments / Reversal of impairments
includes net reversals of impairment
and loss allowances
for credit risk, losses
on irrecoverable loans and amounts recovered on amortised receivables.
2.3.3.4
Offsetting financial assets and financial liabilities
A financial asset
and a
financial liability
are offset and
the net
amount presented on
the statement of
financial position
when the Company has a legally enforceable right
to set off the recognised amounts and intends either to
settle the
asset
and
liability
on
a
net
basis,
or
to
realise
the
asset
and
settle
the
liability
simultaneously.
The legal right to set off the recognised amounts must be
enforceable in all circumstances, in both the normal
course
of business and in the event of default of one of the
counterparties.
The financial instruments issued by the Company are subscribed by the investors
through Société Générale as a lead
manager during the
issuance period and
as a market maker
for a secondary
market. The instruments
which are unsold
are held by SG.
The treatment is
applied based on IAS 32
Paragraph 42: “A
financial asset and a
financial liability shall be offset
and
the net amount presented in the statement of financial position when,
and only when, an entity:
●
Currently has a legally enforceable right to set off the recognized amounts; and
●
Intends either to settle on a net basis, or to realise the asset
and settle the liability simultaneously.”
In December 2014, a
cash netting clause was
added in the legal
framework with Société Générale
Personne Morale
and the Company
consequently acquired a legally
enforceable right to
offset the recognized
amount with the same
counterparty (Société Générale).
The assets (the
Fully Funded Swaps) and
the liabilities (the Notes) are
settled (and
intended to be settled) simultaneously.